These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1646700)

  • 1. Ofloxacin, a bactericidal antibacterial.
    Smith JT
    Chemotherapy; 1991; 37 Suppl 1():2-13. PubMed ID: 1646700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological testing of non-fluorinated analogues of levofloxacin.
    Gray JL; Almstead JI; Gallagher CP; Hu XE; Kim NK; Taylor CJ; Twinem TL; Wallace CD; Ledoussal B
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2373-5. PubMed ID: 12824037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation rates to 4-quinolone resistance.
    Smith JT
    Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 4-quinolones against Pseudomonas aeruginosa.
    Morissey I; Smith JT
    Arzneimittelforschung; 1994 Oct; 44(10):1157-61. PubMed ID: 7818593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the 4-quinolones with other antibacterials.
    Lewin CS; Smith JT
    J Med Microbiol; 1989 Jul; 29(3):221-7. PubMed ID: 2664184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanism of action of quinolones].
    Smith JT
    Infection; 1986; 14 Suppl 1():S3-15. PubMed ID: 2420724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of lomefloxacin and ofloxacin in complex therapy of infections in patients with burns].
    Krutikov MG; Alekseev AA; Bobrovnikov AE; Grishina IA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1998; 43(10):27-31. PubMed ID: 9825107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria.
    Furneri PM; Fresta M; Puglisi G; Tempera G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2458-64. PubMed ID: 10952595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S; Okabe H; Shibata H; Hase T; Nakanishi N; Okezaki E; Kato H; Masamune Y
    Jpn J Antibiot; 1989 Jan; 42(1):193-9. PubMed ID: 2468799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris.
    Ishii H; Sato K; Hoshino K; Sato M; Yamaguchi A; Sawai T; Osada Y
    J Antimicrob Chemother; 1991 Dec; 28(6):827-36. PubMed ID: 1667782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL; Fuchs PC
    J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
    Lewin CS
    J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Quinolone bactericidal mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Arzneimittelforschung; 1993 Oct; 43(10):1125-9. PubMed ID: 7505585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of temperature on mutational resistance to 4-quinolones.
    Parte AC; Smith JT
    Arzneimittelforschung; 1996 Apr; 46(4):429-32. PubMed ID: 8740093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of resistance to quinolones and current level of sensitivity of clinically important microorganisms to ofloxacin].
    Sidorenko SV; Rezvan SP; Makarova RA; Makarov AN; Kozlova NS; Ogneva NS; Korolev IuS; Gladin DP
    Antibiot Khimioter; 1996; 41(9):33-8. PubMed ID: 9005782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.